Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 251 | 179 | 0 | 0 | 0 |
| Gross Profit | 251 | 179 | N/A | N/A | N/A |
| Operating Expenses | 21,030 | 18,668 | 15,539 | 13,724 | 0 |
| Operating Income | -20,779 | -18,489 | -15,539 | -13,724 | N/A |
| Interest Expense | 321 | 202 | 198 | 258 | 0 |
| Other Income | 342 | 324 | 14 | 30 | 0 |
| Pre-tax Income | -20,758 | -18,367 | -15,723 | -13,952 | 0 |
| Net Income Continuous | -20,758 | -18,367 | -15,723 | -13,952 | N/A |
| Net Income | $-20,758 | $-18,367 | $-15,723 | $-13,952 | $N/A |
| EPS Basic Total Ops | 2.50 | -3.12 | -2.90 | -2.71 | N/A |
| EPS Basic Continuous Ops | 2.50 | -3.12 | -2.90 | -2.71 | N/A |
| EPS Diluted Total Ops | 2.50 | -3.12 | -2.90 | -2.71 | N/A |
| EPS Diluted Continuous Ops | 2.50 | -3.12 | -2.90 | -2.71 | N/A |
| EBITDA(a) | $-20,217 | $-18,234 | $-15,285 | $-13,469 | $N/A |